Owkin vs Xaira Therapeutics
Which Healthcare AI tool is better in 2026?
Owkin
Pioneering biological artificial superintelligence to automate R&D and connect research directly to patient care.
Xaira Therapeutics
Pioneering transformative artificial intelligence to discover and develop the next generation of life-changing medicines.
Side-by-side
Owkin is the more established option (raised $354M); pricing is comparable on both sides.
| Metric | Owkin | Xaira Therapeutics |
|---|---|---|
| Taglinei | Pioneering biological artificial superintelligence to automate R&D and connect research directly to patient care. | Pioneering transformative artificial intelligence to discover and develop the next generation of life-changing medicines. |
| Foundedi | 2016🏆 | — |
| HQi | FR | — |
| Employeesi | — | — |
| Neuron scorei | 72🏆 | 60 |
| Total fundingi | $354M🏆 | Undisclosed |
| Latest roundi | Series B · Nov 2021 | — |
| Valuationi | $1B🏆 | — |
| Cheapest paid plani | — | — |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | K Pro License · Contact sales | Enterprise Solutions · Contact sales |
| Pricing summaryi | 1 published plans | 1 published plans |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Owkin and Xaira Therapeutics.
| Capability | Owkin | Xaira Therapeutics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Owkin
- Has raised more capital ($354M vs Undisclosed)
- Higher Neuron score (72 vs 60)
- Newer company (2016)
🔵 Strengths of Xaira Therapeutics
- Strong in AI Healthcare
Which should you choose?
Choose Xaira Therapeutics if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Owkin if you want the most established option — it has raised $354M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Owkin vs Xaira Therapeutics — which is better?
It depends on your priority. Owkin has raised more capital and is the more established option; Xaira Therapeutics has broader feature depth. See the side-by-side table above.
Is Owkin cheaper than Xaira Therapeutics?
No — Xaira Therapeutics's cheapest paid plan is Enterprise · Contact sales, while Owkin's is Enterprise · Contact sales.
Do Owkin and Xaira Therapeutics offer free plans?
Owkin: Paid only. Xaira Therapeutics: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.